Loreto Carmona
#139,771
Most Influential Person Now
Researcher
Loreto Carmona's AcademicInfluence.com Rankings
Loreto Carmonacomputer-science Degrees
Computer Science
#6630
World Rank
#6988
Historical Rank
Computational Linguistics
#1184
World Rank
#1198
Historical Rank
Machine Learning
#2218
World Rank
#2246
Historical Rank
Artificial Intelligence
#2488
World Rank
#2529
Historical Rank
Download Badge
Computer Science
Loreto Carmona's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Loreto Carmona Influential?
(Suggest an Edit or Addition)Loreto Carmona's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. (2003) (1038)
- The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study (2014) (913)
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry (2020) (867)
- Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. (2005) (681)
- The burden of musculoskeletal diseases in the general population of Spain: results from a national survey (2001) (654)
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2008) (464)
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement (2010) (463)
- Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography (2004) (448)
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2021) (446)
- Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. (2007) (430)
- Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. (2007) (367)
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies (2009) (356)
- EULAR recommendations for the management of familial Mediterranean fever (2016) (327)
- Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period (2006) (305)
- The prevalence of rheumatoid arthritis in the general population of Spain. (2002) (278)
- Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. (2008) (272)
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative (2013) (244)
- Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. (2008) (244)
- All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists (2007) (243)
- Increased risk of tuberculosis in patients with rheumatoid arthritis. (2003) (242)
- Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative (2011) (234)
- Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity (2003) (231)
- 2018 update of the EULAR recommendations for the management of hand osteoarthritis (2018) (220)
- Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative (2008) (210)
- 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations (2014) (210)
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (2020) (208)
- Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER (2006) (208)
- Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. (2003) (200)
- Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. (2007) (191)
- Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries (2020) (185)
- A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. (2010) (174)
- Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative (2016) (167)
- The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology (2017) (166)
- Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout (2013) (166)
- Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt– a national health survey (2016) (161)
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study (2020) (155)
- EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases (2016) (150)
- Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease. (2009) (145)
- Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. (2004) (140)
- Economic burden of knee and hip osteoarthritis in Spain. (2009) (138)
- Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. (2014) (131)
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry (2021) (131)
- The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. (2008) (127)
- The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis (2015) (126)
- Early Mortality in a Multinational Systemic Sclerosis Inception Cohort (2017) (125)
- Ultrasonographic assessment of inflammatory activity in rheumatoid arthritis: comparison of extended versus reduced joint evaluation. (2005) (124)
- EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology (2010) (116)
- Lipid Profile Changes in Patients With Chronic Inflammatory Arthritis Treated With Biologic Agents and Tofacitinib in Randomized Clinical Trials: A Systematic Review and Meta‐Analysis (2015) (114)
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists (2010) (108)
- Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials (2013) (104)
- Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). (2009) (101)
- Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. (2008) (100)
- Survival, mortality and causes of death in inflammatory myopathies (2006) (100)
- Cancer in patients with rheumatic diseases exposed to TNF antagonists. (2011) (98)
- Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project (2013) (93)
- Rheumatoid arthritis. (2010) (90)
- Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. (2010) (90)
- Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies (2017) (86)
- Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia (2006) (85)
- Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative (2010) (84)
- Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis (2018) (84)
- Validacion de cuestionarios (2009) (82)
- Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis. (2013) (81)
- Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. (2011) (79)
- Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry (2021) (79)
- Documento de consenso de la Sociedad Espaola de Reumatologa sobre la fibromialgia (2006) (78)
- Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. (2011) (78)
- Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients. (2007) (75)
- Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry. (2011) (74)
- Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. (2011) (73)
- A Health System Program To Reduce Work Disability Related to Musculoskeletal Disorders (2005) (73)
- 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis (2021) (72)
- Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0 (2011) (72)
- Proyecto EPISER 2000: prevalencia de enfermedades reumáticas en la población española.Metodología, resultados del reclutamiento y características de la población (2001) (72)
- A meta-analysis of mortality in rheumatic diseases. (2012) (70)
- A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis. (2011) (67)
- Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? (2008) (64)
- Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. (2010) (64)
- The burden of disease in Spain: results from the global burden of disease study 2010 (2014) (63)
- EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases (2019) (62)
- Prevalence of Vertebral Fractures by Semiautomated Morphometry in Patients with Ankylosing Spondylitis (2011) (62)
- High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort (2015) (61)
- Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis (2013) (60)
- [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients]. (2011) (60)
- The epidemiology of established rheumatoid arthritis. (2020) (60)
- Prevalence, risk factors, and impact of knee pain suggesting osteoarthritis in Spain. (2008) (58)
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19 (2021) (57)
- Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases (2013) (57)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al (2021) (55)
- Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas (2011) (54)
- Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0 (2014) (53)
- Predictors of rate of return to work after surgery for carpal tunnel syndrome. (1998) (52)
- Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life. (2008) (52)
- Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol. (2006) (52)
- Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review. (2012) (51)
- A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control. (2009) (50)
- 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis (2018) (50)
- EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology. (2015) (50)
- Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis (2015) (49)
- Prevalence and associated factors of anterior atlantoaxial luxation in a nation-wide sample of rheumatoid arthritis patients. (2004) (49)
- Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry. (2011) (49)
- Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme (2013) (48)
- Interleukin-1 inhibitors for acute gout. (2014) (48)
- Systematic review and critical appraisal of transitional care programmes in rheumatology. (2016) (47)
- Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project (2014) (46)
- Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. (2015) (45)
- Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. (2003) (45)
- Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0. (2011) (43)
- A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program (2011) (43)
- Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis. (2017) (42)
- Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort (2008) (42)
- Prevalence of Paget's disease of bone in Spain. (2008) (41)
- An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting: The Gout Evaluation and Management Study (2011) (40)
- Limited value of ultrasound assessment in patients with poor outcome after carpal tunnel release surgery (2010) (40)
- Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology (2014) (38)
- Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) (2021) (38)
- Denosumab for the treatment of osteoporosis: a systematic literature review. (2013) (38)
- Aceclofenac, a new nonsteroidal antiinflammatory drug, decreases the expression and function of some adhesion molecules on human neutrophils. (1996) (38)
- The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. (2014) (38)
- Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study. (2012) (38)
- Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment (2017) (37)
- Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. (2011) (37)
- Early spondyloarthritis: results from the pilot registry ESPIDEP. (2010) (36)
- Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality (2019) (35)
- Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. (2014) (35)
- Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis. (2007) (35)
- Predictors of treatment failure and mortality in native septic arthritis (2015) (35)
- Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management (2017) (34)
- Transitional care for rheumatic conditions in Europe: current clinical practice and available resources (2017) (34)
- Characteristics and Outcomes of People With Gout Hospitalized Due to COVID‐19: Data From the COVID‐19 Global Rheumatology Alliance Physician‐Reported Registry (2022) (34)
- Efficacy and safety of home-based exercises versus individualized supervised outpatient physical therapy programs after total knee arthroplasty: a systematic review and meta-analysis (2017) (34)
- Observed and expected frequency of comorbid chronic diseases in rheumatic patients (2007) (34)
- Prognostic factors in short-term disability due to musculoskeletal disorders. (2008) (34)
- Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. (2013) (33)
- Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. (2014) (33)
- Uso apropiado de los antiinflamatorios no esteroideos en reumatología: documento de consenso de la Sociedad Española de Reumatología y el Colegio Mexicano de Reumatología (2009) (32)
- Is Spinal Mobility in Patients With Spondylitis Determined By Age, Structural Damage, and Inflammation? (2015) (31)
- Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. (2017) (31)
- Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases (2021) (31)
- Usefulness of clinical findings, nerve conduction studies and ultrasonography to predict response to surgical release in idiopathic carpal tunnel syndrome. (2009) (30)
- Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance (2022) (29)
- Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study (2017) (29)
- The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments (2014) (28)
- The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries (2017) (28)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al (2021) (28)
- Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. (2009) (28)
- Orthopedic Surgery in Rheumatoid Arthritis in the Era of Biologic Therapy (2013) (28)
- Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset (2015) (28)
- Effectiveness of a clinical practice intervention in early rheumatoid arthritis (2012) (28)
- Epidemiología de la artritis reumatoide (2002) (28)
- Dietary supplements for chronic gout. (2014) (27)
- Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: systematic review and meta-analysis of observational studies. (2014) (27)
- Calcium supplementation and kidney stone risk in osteoporosis: a systematic literature review. (2012) (27)
- Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017) (26)
- Prognostic factors for long-term work disability due to musculoskeletal disorders (2012) (26)
- [Validation of questionnaires]. (2009) (26)
- Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients—The ENMENTE Project (2017) (25)
- Weather conditions and their effect on seasonality of incident osteoporotic hip fracture (2018) (25)
- Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review. (2014) (25)
- Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists (2016) (25)
- The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers. (2015) (25)
- 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice (2020) (24)
- Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products (2017) (24)
- [Responsiveness of outcome measures]. (2008) (23)
- SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases (2021) (23)
- How good is to switch between biologics? A systematic review of the literature. (2007) (23)
- Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study (2021) (23)
- EULAR recommendations for intra-articular therapies (2021) (22)
- Revisión sistemática: eficacia y seguridad del tratamiento anti-TNF en pacientes ancianos (2011) (22)
- Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience (2014) (22)
- Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (2015) (22)
- Sensibilidad al cambio de las medidas de desenlace (2008) (22)
- SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry (2022) (20)
- Validation of a new objective index to measure spinal mobility: the University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI) (2014) (20)
- The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology (2017) (20)
- Implementación y características de la población del estudio ArtRoCad, una aproximación al consumo de recursos y repercusión socioeconómica de la artrosis de rodilla y cadera en atención primaria (2006) (20)
- Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider. (2020) (19)
- Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. (2018) (19)
- BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries. (2014) (18)
- Second Hip Fracture: Incidence, Trends, and Predictors (2018) (18)
- Trends in osteoporotic hip fracture epidemiology over a 17-year period in a Spanish population: Alcorcón 1999–2015 (2017) (18)
- The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments. (2015) (17)
- Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review (2018) (17)
- [Spanish registry of adverse events of biological therapies in rheumatic diseases (BIOBADASER): report as of january 14, 2005]. (2005) (17)
- [Systematic review: safety and efficacy of anti-TNF in elderly patients]. (2011) (17)
- EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs) (2021) (17)
- Impacto del consumo de AINE en la población general española. Resultados del estudio EPISER (2002) (16)
- Recommendations to lower the risk of tuberculosis in patients treated with tumour necrosis factor alpha antagonists. (2006) (16)
- Se asocia la obesidad en la artritis psoriásica a una menor respuesta terapéutica y más efectos adversos con el tratamiento de fondo (2016) (16)
- Translating patient reported outcome measures: methodological issues explored using cognitive interviewing with three rheumatoid arthritis measures in six European languages. (2016) (15)
- Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas (2008) (15)
- Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study (2021) (15)
- Is obesity in psoriatic arthritis associated with a poorer therapeutic response and more adverse effects of treatment with an anchor drug? (2016) (15)
- Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria (2019) (14)
- Development and Validation of a New Disease Activity Index as a Numerical Sum of Four Variables in Patients With Early Arthritis (2013) (14)
- Efficacy and safety of DMARDs in psoriatic arthritis: a systematic review. (2012) (14)
- Patient–physician collaboration in rheumatology: a necessity (2017) (14)
- Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes. (2017) (14)
- Estudio sobre el manejo de la artritis reumatoide en España (emAR II). Características clínicas de los pacientes (2012) (14)
- Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice. (2009) (14)
- Prevalence of silent amyloidosis in RA and its clinical significance. (2004) (13)
- Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. (2018) (13)
- Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database (2018) (13)
- Revisión sistemática: ¿es recomendable el empleo de toxina botulínica como tratamiento del dolor en el síndrome miofascial? (2006) (13)
- Abatacept use in rheumatoid arthritis: evidence review and recommendations. (2013) (13)
- Índices compuestos para evaluar la actividad de la enfermedad y el daño estructural en pacientes con lupus eritematoso: revisión sistemática de la literatura (2014) (13)
- Utilización de recursos en una cohorte de pacientes con artritis reumatoide atendidos en área especializada de reumatología en España (2005) (12)
- Características de los pacientes con espondiloartritis seguidos en unidades de reumatología en España. Estudio emAR II (2012) (12)
- Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report (2017) (12)
- Análisis de costes en una cohorte de enfermos con artritis reumatoide atendidos en área especializada de reumatología en España (2005) (12)
- El uso de abatacept en artritis reumatoide: revisión de la evidencia y recomendaciones (2013) (12)
- Características de una unidad de artritis precoz que mejoran la eficiencia de la derivación: encuesta a las unidades SERAP (2011) (12)
- Algorithm for Identification of Undifferentiated Peripheral Inflammatory Arthritis: A Multinational Collaboration Through the 3e Initiative (2011) (11)
- Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study. (2012) (11)
- Análisis de costes en una cohorte de enfermos con artritis reumatoide atendidos en área especializada de reumatología en España (2005) (11)
- Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients. (2012) (11)
- [Biobadaser 2.0: analysis and trends in 2009]. (2010) (11)
- Facilitators to implement standards of care for rheumatoid arthritis and osteoarthritis: the EUMUSC.NET project (2014) (10)
- [Appropriate use of non-steroidal anti-inflammatory drugs in rheumatology: guidelines from the Spanish Society of Rheumatology and the Mexican College of Rheumatology]. (2009) (10)
- Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach? (2017) (10)
- Interleukin‐1 inhibitors for chronic gout (2012) (10)
- Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis. (2004) (10)
- Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis (2016) (10)
- Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic. (2016) (10)
- [Adverse Reactions Related to the Administration of TNF Inhibitors. Analysis of a Registry of Biologic Therapy]. (2008) (9)
- [Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain]. (2005) (9)
- Revisión sistemática: ¿el diagnóstico en sí de fibromialgia tiene algún efecto deletéreo sobre el pronóstico? (2006) (9)
- Is Obesity in Psoriatic Arthritis Associated With a Poorer Therapeutic Response and More Adverse Effects of Treatment With an Anchor Drug (2016) (9)
- Barriers and Facilitators for the Practice of Physical Exercise in Patients With Spondyloarthritis: Qualitative Study of Focus Groups (EJES-3D). (2017) (9)
- Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis (2019) (8)
- Incidence of Physical Disability Related to Musculoskeletal Disorders in the Elderly: Results From a Primary Care–Based Registry (2015) (8)
- The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3 (2017) (8)
- Actualizacion de BIOBADASER (2009) (8)
- Adverse Reactions Related to the Administration of TNF Inhibitors. Analysis of a Registry of Biologic Therapy (2008) (8)
- Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study (2021) (8)
- Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists. (2013) (8)
- [Systematic review: can botulinum toxin be recommended as treatment for pain in myofascial syndrome?]. (2006) (8)
- Databases and registers: useful tools for research, no studies (2014) (8)
- The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients (2020) (8)
- Quality-of-care standards for early arthritis clinics (2013) (8)
- [What are patients with early rheumatoid arthritis like in Spain? Description of the PROAR cohort]. (2009) (8)
- EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries (2020) (8)
- Motivations and objections to implement a spondyloarthritis integrated care pathway. A qualitative study with primary care physicians. (2013) (8)
- Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews (2021) (8)
- Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis (2016) (8)
- Reccomendations for the detection, study and referral of inflammatory low-back pain in primary care. (2015) (8)
- Effect of weight loss on activity in psoriatic arthritis: A systematic review. (2017) (7)
- Revisión sistemática: ¿el diagnóstico en sí de fibromialgia tiene algún efecto deletéreo sobre el pronóstico? (2006) (7)
- Quantifying risks: the case between glucocorticoids and tuberculosis. (2006) (7)
- Influencia del género en la respuesta al tratamiento en una cohorte de pacientes con artritis reumatoide precoz del área 2 de la Comunidad de Madrid (2010) (7)
- Effect of an abdominal hypopressive technique programme on pelvic floor muscle tone and urinary incontinence in women: a randomised crossover trial. (2020) (7)
- [Characteristics of early arthritis units that may be associated with better referral efficiency: survey of SERAP units]. (2011) (7)
- Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis (2021) (7)
- Something new about prognostic factors for lupus nephritis? A systematic review (2021) (7)
- The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches (2018) (7)
- ESTUDIO DE ALGUNOS ELEMENTOS TRAZA EN CARBONES DE LA CUENCA CESAR - RANCHERIA, COLOMBIA (2007) (7)
- Revisión sistemática: ozonoterapia en enfermedades reumáticas (2006) (7)
- Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey (2015) (7)
- Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review. (2014) (7)
- The practical value of biologics registries in Africa and Middle East: challenges and opportunities (2012) (7)
- Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento (2020) (7)
- Clinical Composite Measures of Disease Activity for Diagnosis and Followup of Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (7)
- Variability in Resource Consumption in Patients With Spondyloarthritis in Spain. Preliminary Descriptive Data From the emAR II Study (2012) (6)
- High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis (2018) (6)
- Infections in patients with rheumatic diseases treated with TNF antagonists. (2012) (6)
- Tackling missing radiographic progression data: multiple imputation technique compared with inverse probability weights and complete case analysis. (2013) (6)
- Treatment target and followup measures for patients with gout: a systematic literature review. (2014) (6)
- ¿Como son los pacientes con artritis reumatoide de reciente comienzo en Espana? Descripcion de la cohorte PROAR (2009) (6)
- Características de la enfermedad ósea de Paget en España. Datos del Registro Nacional de Paget (2009) (6)
- Perioperative management of disease modifying anti-rheumatic drugs: Recommendations based on a meta-analysis (2012) (6)
- Meta-analysis in the era of big data (2019) (6)
- Recomendaciones para la detección, investigación y derivación del dolor lumbar inflamatorio en Atención Primaria (2015) (6)
- Recomendaciones para la prescripción de ejercicio físico en pacientes con espondiloartritis (2017) (6)
- Registro español de acontecimientos adversos de terapias biológicas en enfermedades reumáticas (BIOBADASER): informe de la situación a 14 de enero de 2005 (2005) (6)
- Utilización de recursos en una cohorte de pacientes con artritis reumatoide atendidos en área especializada de reumatología en España (2005) (6)
- Cambios entre anti-TNF, ¿están siempre justificados? (2008) (6)
- Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence (2018) (6)
- [Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain]. (2005) (5)
- Clinical Outcomes of Patients with COVID-19 and Chronic Inflammatory and Autoimmune Rheumatic Diseases: A Multicentric Matched-Cohort Study (2020) (5)
- [Management of spondyloarthritis (ESPOGUIA): methodology and general data from the document]. (2010) (5)
- EULAR COVID-19 registry: lessons learnt and future considerations (2021) (5)
- Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment. (2019) (5)
- Effect of Weight Loss on Activity in Psoriatic Arthritis: A Systematic Review (2018) (5)
- Despair on disparities (2009) (5)
- Recomendaciones para el manejo de la comorbilidad en la práctica clínica en pacientes con espondiloartritis axial (2017) (5)
- Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study (2020) (5)
- Early mortality in Australian, Canadian and Spanish scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis (2014) (5)
- Is there a best way to measure co-morbidity? (2014) (4)
- Epidemiology of rheumatic and musculoskeletal diseases. (2018) (4)
- Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study (2022) (4)
- Cambios entre anti-TNF, ¿están siempre justificados? (2008) (4)
- Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión (2010) (4)
- [Not Available]. (2006) (4)
- [Anti-TNF therapy and cancer]. (2010) (4)
- OP0006 ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (2021) (4)
- 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension. (2017) (4)
- Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: three centers experience. (2013) (4)
- Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. (2018) (4)
- Efecto de la pérdida de peso en la actividad en artritis psoriásica: una revisión sistemática (2017) (4)
- Factores motivadores y barreras para implantar una vía clínica de atención precoz de espondiloartritis: estudio cualitativo con médicos de atención primaria (2013) (4)
- The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (2018) (4)
- [Influence of gender on treatment response in a cohort of patients with early rheumatoid arthritis in the area 2 of Madrid]. (2010) (4)
- [Ozone therapy in rheumatic diseases: a systematic review]. (2006) (4)
- Diagnostic and Prognostic Value of Genetics in Undifferentiated Peripheral Inflammatory Arthritis: A Systematic Review (2011) (4)
- Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs (2019) (4)
- Reducing the Need for Central Dual-Energy X-Ray Absorptiometry in Postmenopausal Women: Efficacy of a Clinical Algorithm Including Peripheral Densitometry (2013) (4)
- [Systematic review: are major opioids effective in the treatment of musculoskeletal pain?]. (2007) (4)
- Recommendations for the prescription of physical exercise for patients with spondyloarthritis. (2019) (4)
- Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ (2019) (4)
- Ensuring the Consistency of Biosimilars. (2017) (4)
- Outcomes Reported in Prospective Long‐Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review (2020) (3)
- Consensus Statement on the Management of Comorbidity in Patients with Rheumatoid Arthritis and Psoriasis (2016) (3)
- P508 Drug survival and reasons for discontinuation of anti-TNF therapy in inflammatory bowel disease (IBD) in clinical practice (2014) (3)
- Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. (2017) (3)
- The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective. (2018) (3)
- Practical Aspects of Biological Throughput Levels and Antidrug Antibodies in Rheumatoid Arthritis and Spondyloarthritis. (2018) (3)
- SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (2022) (3)
- Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review. (2021) (3)
- Overview of changes in RMD epidemiology and outcome development in the last 10 years. (2018) (3)
- Actualización de BIOBADASER (2009) (3)
- Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022) (3)
- [Peri-operative management of disease modifying anti-rheumatic drugs: recommendations based on a meta-analysis]. (2012) (3)
- Barreras y facilitadores para la práctica del ejercicio físico en pacientes con espondiloartritis: estudio cualitativo de grupos focales (EJES-3D) (2017) (3)
- [ArtRoCad: health resources utilization and socioeconomic impact of knee and hip osteoarthritis. I. Methods and population characteristics]. (2006) (3)
- Impacto psicosocial y su manejo en enfermedad inflamatoria intestinal. El punto de vista de los pacientes (2018) (3)
- FRI0291 SAFETY AND SURVIVAL OF SECUKINUMAB IN SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: REAL-LIFE DATA. A MULTICENTER STUDY (2020) (2)
- Revisión sistemática: ozonoterapia en enfermedades reumáticas (2006) (2)
- Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte II: síndrome antifosfolípido obstétrico y situaciones especiales (2020) (2)
- Artritis reactiva por Salmonella hadar en la epidemia de gastroenteritis asociada al consumo de pollo precocinado en España (2007) (2)
- Satisfacción, cumplimento de expectativas y adherencia al fármaco biológico subcutáneo en pacientes con artritis reumatoide. Estudio ARCO (2020) (2)
- Variabilidad en el consumo de recursos en pacientes con espondiloartritis en España. Datos descriptivos preliminares del estudio emAR II (2012) (2)
- THU0469 QUANTIFYING THE PLACEBO EFFECT AFTER INTRA-ARTICULAR INJECTIONS: IMPLICATIONS FOR TRIALS AND PRACTICE (2020) (2)
- SAT0559 Systematic literature review (SLR) for the 2018 update of the eular management recommendations for hand osteoarthritis (OA) (2018) (2)
- Assessment of multiple organ systems in systemic lupus erythematosus: what will the new guidelines mean? (2010) (2)
- OP0052 FAILURE TO REACH SERUM URATE TARGET IS ASSOCIATED WITH ELEVATED MORTALITY IN GOUT (2019) (2)
- Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis (2020) (2)
- A full new enthusiastic team (2013) (2)
- Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake (2022) (2)
- Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. (2021) (2)
- Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis. (2022) (2)
- AB1195 Development and validation of an ultrasonographic activity score (USAS) for rheumatoid arthritis (2018) (2)
- Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation (2019) (2)
- Mortality rate is reduced in ra patients treated with TNF antagonists. Data from biobadaser (2006) (2)
- An early intervention program for subacute physical disability related to musculoskeletal diseases in the elderly: a pilot study (2015) (2)
- AB1318 Practical aspects of biological-drug monitoring in rheumatoid arthritis and spondyloarthritis (2018) (2)
- Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review (2022) (2)
- More evidence on the dysautonomic nature of fibromyalgia: the association with short stature. (2002) (2)
- P736 Psychological impact of inflammatory bowel disease: differences by gender and age. The ENMENTE Project. (2017) (2)
- Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice. (2018) (2)
- Intra-articular therapies: patient preferences and professional practices in European countries (2021) (2)
- Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: The RHEU-LIFE survey. (2020) (2)
- The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity (2018) (2)
- Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice (2018) (2)
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers (2021) (2)
- Perceptions of Patients With Rheumatic Diseases Treated With Subcutaneous Biologicals on Their Level of Information: RHEU-LIFE Survey (2019) (1)
- AB0718 Prevalence of risk factors for fractures in axial spondyloarthritis: a systematic review (2017) (1)
- Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. (2020) (1)
- Dietary supplements for chronic gout (Protocol) (2012) (1)
- Web figure 1 (2013) (1)
- Switching Between Anti-TNF: Is it Always Justified? (2008) (1)
- AB0579 ANTI-JO1 ANTIBODIES IN A REAL-WORLD POPULATION. (2020) (1)
- AB0657 ANTISYNTHETASE SYNDROME: NON-ANTISYNTHETASE ANTIBODIES, CLINICAL MANIFESTATIONS AND OVERLAPS (2019) (1)
- THU0642 EULAR POINTS TO CONSIDER FOR THE DEVELOPMENT, EVALUATION AND IMPLEMENTATION OF MOBILE HEALTH APPLICATIONS FOR SELF-MANAGEMENT IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (2019) (1)
- [Characteristics of Paget's disease in Spain. Data from the National Paget's Register]. (2009) (1)
- Reducing bureaucracy in clinical trials, now is the time! (2022) (1)
- Manejo perioperatorio de los fármacos modificadores de la enfermedad en Reumatología, recomendaciones basadas en un metaanálisis (2012) (1)
- Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression (2021) (1)
- Severity indices in rheumatoid arthritis: A systematic review. (2019) (1)
- Índices de gravedad en la artritis reumatoide: una revisión sistemática (2017) (1)
- Erratum to: Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (2015) (1)
- Perceptions of patients with rheumatic diseases treated with subcutaneous biologicals on their level of information: RHEU-LIFE Survey. (2017) (1)
- Documento práctico para el uso de abatacept subcutáneo (2014) (1)
- THU0633 The Revised Bristol RA Fatigue Nrs, Containing New Nrs-Coping Anchors (Braf-NRS V2 Revised): Validity across 6 European Countries (2016) (1)
- Facing arthritis: helping patients to handle their disease and concerns (2019) (1)
- NSAIDs, analgesics and opioids agents for fibromyalgia syndrome (2007) (1)
- OP0052 Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from Epireumapt, A National Health Survey (2015) (1)
- THU0148 Economic Considerations and Patients' Preferences Affect Treatment Selection for Rheumatoid Arthritis Patients: A Discrete Choice Experiment among European Rheumatologists (2016) (1)
- Aspectos prácticos de la medición de los niveles de fármacos biológicos y de anticuerpos antifármaco en artritis reumatoide y espondiloartritis (2020) (1)
- The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods (2012) (1)
- Revisión sistemática: ¿son eficaces los opiáceos mayores en el tratamiento del dolor osteomuscular? (2007) (1)
- FRI0367 Fatigue is an Internationally Valid Concept: The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) in 6 EU Countries (2015) (1)
- Revisión sistemática: ¿son eficaces los opiáceos mayores en el tratamiento del dolor osteomuscular? (2007) (1)
- Percepciones de los pacientes con enfermedades reumáticas tratados con biológicos subcutáneos sobre su nivel de información. Encuesta RHEU-LIFE (2017) (1)
- [Systematic review: does a diagnosis of fibromyalgia per se have a harmful effect on prognosis?]. (2006) (1)
- [Update of BIOBADASER]. (2009) (1)
- OP0262-PARE What is the Knowledge Level that Ankylosing Spondylitis Patients Have About their Own Disease? (2013) (1)
- THU0548 Standardised procedures for ultrasound imaging in paediatric rheumatology: progress of eular/pres task force (2018) (1)
- The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study (2018) (1)
- AB0656 ANTISYNTHETASE SYNDROME: CLINICAL VALUE OF SOLOMON’S AND CONNORS’ DIAGNOSIS CRITERIA (2019) (1)
- Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists (2020) (1)
- A10.24 Switching Infliximab for New Alternatives: A Correspondence Analysis of Biologics, Reasons to Stop, and Time Periods (2013) (1)
- PROMs for Fibromyalgia (2016) (1)
- OP0340 Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal observational studies (2017) (1)
- Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry (2022) (1)
- Origins of erosive arthritis. (2005) (1)
- Patient's experiences of the barriers and facilitators to Methotrexate. (2021) (1)
- "There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective. (2019) (1)
- FRI0190 Cognitive Interviewing is Crucial in Translating Patient Reported Outcome Measures (PROMS): an International Study in 6 Countries (2014) (1)
- SP0016 The ABC of Diagnostic and Prognostic Tests (2014) (1)
- Erratum to: The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology (2017) (1)
- Use of Parenteral Methotrexate in Rheumatic Diseases: A Systematic Review. (2021) (1)
- Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit. (2019) (1)
- OP0268 The Eular Outcome Measure Library, An Evolutional Database of Validated Patient-Reported Outcomes: Use and Dissemination in The First Two Years (2016) (1)
- Severity Indices in Rheumatoid Arthritis: A Systematic Review (2019) (1)
- SAT0138 DRUG-RELATED PANCYTOPENIA AND LEUKOPENIA IN RHEUMATOID ARTHRITIS: ARE ALL CSDMARDS EQUAL? (2020) (1)
- OP0281 Rheumatologists Consider Patient Preferences and Costs when Choosing Treatments for Rheumatoid Arthritis (RA) Patients. A Cross-European Discrete Choice Experiment (2015) (1)
- OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA) (2021) (1)
- P490 Evolution of the first-line biologic treatment and cost derived from biologic therapy from year 2000: Results of the Biologic Therapies Unit (BTU) at Hospital Universitario de La Princesa (2014) (0)
- Practice guidelines for the use of subcutaneous abatacept. (2014) (0)
- PARE0017 Recommendations for Rheumatologists on Physical Exercise in Spondyloarthritis (EJES 3-D Study) (2015) (0)
- Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey. (2021) (0)
- The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods (2012) (0)
- PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0 (2013) (0)
- FRI0071 ANALYSIS OF DATA GAPS IN RHEUMATOID ARTHRITIS (2020) (0)
- OP0348 PARE FACE ARTHRITIS: WHAT SITUATIONS AFFECT EMOTIONALLY THE PATIENT WITH RHEUMATOID ARTHRITIS AND HOW TO RESOLVE THEM EFFECTIVELY (2019) (0)
- SP0183 To Publish or Perish: How to Review Manuscripts and Grant Proposals (2015) (0)
- Rheumatoid Arthritis Impact of Disease Questionnaire (2020) (0)
- SP0189 Meta-Analysis Presentation, Interpretation and Relevance (2015) (0)
- Safety and efficacy in the nursing care of people with rheumatic diseases on janus kinase inhibitor therapy (2022) (0)
- SAT0608-HPR EULAR POINTS TO CONSIDER FOR THE DETECTION, ASSESSMENT AND MANAGEMENT OF NON-ADHERENCE IN PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (2020) (0)
- Epidemiological characteristics and adverse events of patients with psoriatic arthritis undergoing treatment with biological therapies in Galicia (2021) (0)
- Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023) (0)
- Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance (2022) (0)
- AB1004 Sources of Information Used by Patients with Rheumatic Diseases Treated with Subcutaneous Biological Therapy. Rheu-Life Survey (2016) (0)
- otivations and Objections to Implement a Spondyloarthritis Integrated Care athway . A Qualitative Study With Primary Care Physicians (2019) (0)
- AB1065 Diagnosing gout without joint fluid aspiration: A systematic literature review using monosodium urate crystals as a reference standard (2013) (0)
- SAT0583 A Systematic Review of Systemic Sclerosis Instruments for The Eular Outcome Measures Library: An Evolutionary Database of Validated Patient-Reported Instruments (2016) (0)
- Dietary supplements for chronic gout. (2021) (0)
- AB0373 PSYCHOMETRIC PROPERTIES OF OUTCOME MEASUREMENT INSTRUMENTS FOR LARGE VESSEL VASCULITIS: A SYSTEMATIC LITERATURE REVIEW (2021) (0)
- SP0092 Deciding which Journals to Read Regularly: How to Manage One’s Way Through the Medical Information Jungle Without Getting Lost or Eaten Alive (2013) (0)
- P183 Psychosocial impact of inflammatory bowel disease and its practice management as perceived by patients and physicians in Spain. The ENMENTE Project. (2017) (0)
- FRI0427 EULAR RECOMMENDATIONS FOR INTRA-ARTICULAR TREATMENTS FOR ARTHROPATHIES (2020) (0)
- THU0549 Systemic treatment for acute anterior uveitis (synthetic and biologic disease-modifying antirheumatic drugs): a systematic review (2017) (0)
- [Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression]. (2010) (0)
- FRI0294 The Accuracy of Osteoporotic Fracture Risk Prediction Tools: A Systematic Review and Meta-Analysis (2015) (0)
- Corrigendum to "Overview of changes in RMD epidemiology and outcome development in the last 10 years" [Best Pract Res Clin Rheumatol 32 (2018) 169-173]. (2018) (0)
- PARE0006 Facilitators and Barriers of Patients with SPA to Physical Exercise (2015) (0)
- Musculoskeletal and Gait Characteristics in Patients with Stickler Syndrome: A Cross-Sectional Study (2022) (0)
- SAT0275 PERFORMANCE OF THE ANTISYNTHETASE ANTIBODIES AND THEIR INDIRECT IMMUNOFLUORESCENCE PATTERNS IN THE ANTISYNTHETASE SYNDROME DIAGNOSIS (2019) (0)
- SAT0295 Tool for the prescription of exercise in spondyloarthritis with multimedia animations (EJES-3D): pilot study (2018) (0)
- Data for: A randomized cross-over trial of an abdominal hypopressive technique program on pelvic floor muscle tone and urinary incontinence in women (2021) (0)
- antagonists rheumatic diseases treated with TNF shingles and chickenpox in patients with Incidence and risk of hospitalisation due to (2010) (0)
- THU0593 Validity of The Bristol RA Fatigue Multi-Dimensional Questionnaire (BRAF-MDQ) and Rheumatoid Arthritis Impact of Disease (RAID) Scale across 6 European Countries (2016) (0)
- More, none, less therapeutic effect? Should we start talking about a 'lessebo' effect? (2021) (0)
- [Not Available]. (2008) (0)
- Reporting Ultrasound Studies in RMDs 2 (2021) (0)
- Inflammatory Arthritis: A Systematic Review Diagnostic and Prognostic Value of Genetics in Undifferentiated Peripheral (2011) (0)
- SAT0406 Prevalence of vertebral fractures in axial spondyloarthritis. a systematic review of observational studies (2017) (0)
- Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products [Corrigendum] (2019) (0)
- AB1331 Serum drug levels in the management of rheumatoid arthritisand spondyloarthritis: a systematic review (2018) (0)
- AB0774 Does prescription year influence the pattern of biologics use for rheumatoid arthritis? (2013) (0)
- AB1066 Quality of life and disability assessment in gout: A systematic literature review (2013) (0)
- SAT0442 Standardised core indicators of musculoskeletal health across europe: The eumusc.net project (2013) (0)
- SP0066 HOW TO IMPROVE YOUR TEACHING SKILLS (2019) (0)
- Efecto de la pérdida de peso en la actividad en artritis psoriásica: una revisión sistemática (2018) (0)
- Searching for a prognostic index in lupus nephritis (2023) (0)
- POS0181 HOW FIT ARE THE SOCIAL SUPPORT INSTRUMENTS USED IN RMDS: A SYSTEMATIC REVIEW OF VALIDATION STUDIES (2021) (0)
- [Not Available]. (2005) (0)
- AB1124-HPR Key Aspects of Health Professionals Required To Be Experts in Rheumatic Diseases (Reumappa) (2016) (0)
- P397 Approach and management of psychological aspects of inflammatory bowel disease described by patients and physicians in Spain. The ENMENTE Project. (2017) (0)
- Predicting toxicity: biomarkers and the value of the patient's opinion. (2014) (0)
- THU0517 Women with Gout Show A Poorer Cardiovascular Profile after Structured Assessment (2016) (0)
- Estado de la densidad mineral ósea y frecuencia de osteoporosis y de fracturas clínicas en 155 pacientes con artritis psoriásica evaluados en un hospital universitario (2014) (0)
- Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab. (2022) (0)
- What do patients on methotrexate need and expect at the clinic? An online patient survey (2022) (0)
- Einternational panel of rheumatologists in the research and expert opinion of a broad arthritis : integrating systematic literature undifferentiated peripheral inflammatory on how to investigate and follow-up Multinational evidence-based recommendations (2010) (0)
- Epidemiología de las enfermedades reumáticas (2000) (0)
- FRI0646-HPR MAPPING THE PATIENT JOURNEY OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: PERSPECTIVE OF PROFESSIONALS AND PATIENTS (2020) (0)
- HOW GOOD I S T O S WITCH B ETWEEN B IOLOGICS ? A S YSTEMA T IC R EVIEW O F T HE L ITERA T URE . (2007) (0)
- AB1192 Epidemiology of juvenile idiopathic artritis-associated uveitis in spain: Results from a national registry (2013) (0)
- POS1213 IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN ON WELLBEING ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) (2021) (0)
- FRI0458 Assessment of Comorbidity in Psoriatic Disease: How Often Should Be Performed? (2016) (0)
- Corrigendum to "Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes [Semin Arthritis Rheum 46(5) (2017) 609-614]. (2017) (0)
- Mortalidad en las enfermedades reumáticas: un metaanálisis (2012) (0)
- POS0156 PATIENT INVOLVEMENT IN REGISTRIES BASED RESEARCH (2022) (0)
- Epidemiological Characteristics and Adverse Events of Patients with Psoriatic Arthritis Undergoing Treatment with Biological Therapies in Galicia. (2019) (0)
- Is there a best way to measure comorbidity ? Validity of self-administered comorbidity questionnaires (2014) (0)
- AB1370 Patient reported outcomes measuresfor fibromyalgia: a review (2018) (0)
- PARE0027 PATIENT PERSPECTIVE ON INTRA-ARTICULAR THERAPIES IN RMDS: RESULTS FROM A EUROPEAN SURVEY (2020) (0)
- SAT0443 The impact of musculoskeletal conditions across europe: Availability of routinely collected data. The eumusc.net project (2013) (0)
- SP0027 Confounding - Friend or Foe? How To Handle? (2016) (0)
- Use of parenteral methotrexate in rheumatic diseases: A systematic review. (2022) (0)
- PARE0006 Identification and Prioritization of Resources for Rheumatic Patients (Reumappa) (2016) (0)
- [Not Available]. (2007) (0)
- Características clínicas de los pacientes (2016) (0)
- Evidencia de la eficacia de los opioides mayores y menores en el tratamiento del dolor osteoarticular (2008) (0)
- Guía práctica para el manejo de las espondiloartritis (ESPOGUIA): metodología y datos generales del documento (2000) (0)
- AB0736 Strategy for the Early Detection and Referral of Patients with Suspected Spondyloarthritis (2014) (0)
- SAT0636-HPR PATIENT EXPERIENCE WITH THE PRESCRIPTION, INFORMATION AND USE OF METHOTREXATE (2020) (0)
- [Not Available]. (2006) (0)
- Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis (2016) (0)
- Estudio prospectivo multicéntrico de experiencia en práctica clínica real en el control de medidas de desenlace reportadas por el paciente (PRO) diagnosticado de artritis psoriásica y/o espondiloartritis y que inicia tratamiento con secukinumab (2020) (0)
- AB0237 WHAT DO SPANISH RHEUMATOLOGISTS THINK ABOUT THE EFFICACY OF THE DRUGS USED IN THE MANAGEMENT OF PATIENT WITH RHEUMATOID ARTHRITIS AND POOR PROGNOSIS FACTORS? PROGRESAR-2 PROJECT (2019) (0)
- Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde? (2006) (0)
- The psychosocial impact of inflammatory bowel disease and its management. From the patients’ perspective (2018) (0)
- SAT0063 THE COMBINED VACCINATION SCHEME AGAINST STREPTOCOCCUS PNEUMONIAE IS EFFECTIVE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DMARD: DATA FROM BIOBADASER 3.0 (2020) (0)
- AB1139 Centre Characteristics Determine Ambulatory Care and Referrals in Patients with Spondyloarthritis (2015) (0)
- ANÁLISIS DE LIBERACIÓN DE LOS GRUPOS DE MACERALES DEL CARBÓN (2007) (0)
- Características epidemiológicas y eventos adversos de los pacientes con artritis psoriásica en tratamiento con terapias biológicas en Galicia (0)
- ¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide? Posición en contra (2006) (0)
- Proposal for updating the Health Assessment Questionnaire. (2022) (0)
- Sesgos de género en la reumatología española: Percepciones y realidad (2023) (0)
- Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group. (2022) (0)
- Fe de errores de «Mortalidad en las enfermedades reumáticas: un metaanálisis» (2013) (0)
- no estructural en pacientes con lupus eritematoso: revisión sistemática de la literatura (2016) (0)
- Propuesta de actualización del Health Assessment Questionnaire (2022) (0)
- Revisión sistemática del uso de metotrexato por vía parenteral en enfermedades reumáticas (0)
- AB0698 REAL CLINICAL PRACTICE IN THE CONTROL OF REPORTED OUTCOMES BY THE PATIENT (PROS) DIAGNOSED WITH PSORIATIC ARTHRITIS AND/OR ANKYLOSING SPONDYLITIS WHO BEGIN TREATMENT WITH SECUKINUMAB. A PROSPECTIVE MULTICENTRIC STUDY. (2020) (0)
- Web figure 2 (2013) (0)
- Unmet need for patient involvement in rheumatology registries and observational studies: a mixed methods study (2022) (0)
- SP0016 YOUR VERY FIRST STEPS ON SYSTEMATIC REVIEW (2019) (0)
- in the 3E Initiative of a broad international panel of rheumatologists systematic literature research and expert opinion with a focus on rheumatoid arthritis: integrating disorders for the use of methotrexate in rheumatic Multinational evidence-based recommendations (2009) (0)
- Perioperative management of immunosuppression (2016) (0)
- A PROPOSAL FOR THE DEFINITION OF EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS FROM AN INTERNATIONAL CONSENSUS PROMOTED BY THE ITALIAN SOCIETY FOR RHEUMATOLOGY (SIR) (2016) (0)
- [Not Available]. (2006) (0)
- FRI0651 Observational reproducibility study of uco-track©, an automatized measurement of mobility, in patients with axial spondyloarthritis (2017) (0)
- Clinical pathway for patients with spondyloarthritis/Vía clínica para pacientes con espondiloartritis (2012) (0)
- THU0333 Recommendations for Screening of Frequent Comorbidities are Sparse and Incomplete in Chronic Inflammatory Rheumatic Diseases: A Systematic Literature Review for a Eular Project (2015) (0)
- Estudio sobre el manejo de la artritis reumatoide en España (emAR II). Características clínicas de los pacientes (2012) (0)
- FRI0572 Social and Emotional Impact of Rheumatic Diseases in Patients Treated with Subcutaneous Biological Therapy. Rheu Life Survey (2016) (0)
- FRI0566 Attributes of The Subcutaneous Biologic Therapy Preferred by Patients with Rheumatic Disease and Satisfaction with The Treatment. RHEU LIFE Survey (2016) (0)
- AB0675 COUNTRY COMPARISON ON THE IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) (2021) (0)
- SP0102 Understanding the language of health services articles (2018) (0)
- Launch and Preliminary Analysis of Hospital de La Princesa's Inter-specialists Biological Therapies Unit (2019) (0)
- AB0677 GENDER DIFFERENCES ON THE IMPACT OF THE COVID-19 PANDEMIC AND LOCKDOWN IN PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) (2021) (0)
- AB0723 Technical aids agreed among specialists for the management of comorbidity in patients with axial spondyloarthritis: the gecoax project (2017) (0)
- Quality of Life in Children and Adolescents with Stickler Syndrome in Spain (2022) (0)
- AB1362-HPR COMMON PRACTICE IN DELIVERY OF INTRA-ARTICULAR THERAPIES IN RMDS BY HEALTH PROFESSIONALS: RESULTS FROM A EUROPEAN SURVEY (2020) (0)
- Terapias anti-TNF y neoplasias (2010) (0)
- Comparative Risks of Leukopenia, Pancytopenia, Infections, Cardiovascular Events, and Malignancy with First Line Conventional Synthetic Disease-Modifying Antirheumatic Drugs (CsDMARDs) in Rheumatoid Arthritis: An International Multinational Network Cohort Study (2022) (0)
- THU0246 Prevalence of specific comorbid conditions in a nation-wide cohort of rheumatoid arthritis patients (2001) (0)
- AB0834 A Proposal of Definition of Early Symptomatic Knee Osteoarthritis (Eskoa). Results from an International Consensus Promoted by the Italian Society of Rheumatology (Sir) (2015) (0)
- THU0653-HPR BARRIERS FOR THE UPTAKE OF EULAR POSTGRADUATE EDUCATION FOR HEALTH PROFESSIONALS IN RHEUMATOLOGY IN EASTERN EUROPEAN COUNTRIES: RESULTS FROM 3 NATIONAL SURVEYS (2020) (0)
- Recommendations for the Prescription of Physical Exercise for Patients With Spondyloarthritis (2019) (0)
- THU0468 EFFICACY AND SAFETY OF INTRA-ARTICULAR THERAPIES IN RHEUMATIC AND MUSCULOSKELETAL DISEASES: AN OVERVIEW OF SYSTEMATIC REVIEWS INFORMING THE 2020 EULAR RECOMMENDATIONS FOR INTRA-ARTICULAR THERAPIES INCLUDING SYNOVIORTHESIS (2020) (0)
- ¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide?. Posición en contra (2006) (0)
- SAT0387 “do not do” recommendations in the management of comorbidity in patients with axial spondyloarthritis. gecoax project (2017) (0)
- THU0518 New Cardiovascular Risk Factors Screening in Patients with Gout (2016) (0)
- AB1046 A Meta-Analysis of Mortality in Rheumatoid Arthritis (2014) (0)
- Second Hip Fracture: Incidence, Trends, and Predictors (2017) (0)
- SP0031 The EUMUSC.NET Project (2013) (0)
- SAT0140 Recommendations for Investigating and Managing Comorbidity in Rheumatoid Arthritis (2014) (0)
- Denosumab para el tratamiento de la osteoporosis: revision sistemática de la literatura (2013) (0)
- FRI0557 Estimation for the remision cutoff point for hospital universitario de la princesa index (HUPI) in a longitudinal cohort of arthritis of recent onset. validation in a long-term arthritis register. (2013) (0)
- THU0731-HPR The abdominal hypopressive technique can be used to treat low back pain? (2018) (0)
- FRI0086 Is the discordance between the doctor and the patient a determinant of adherence? (2018) (0)
- AB1252 CAN THE HUPI BE MORE USEFUL THAN OTHER INDICES IN THE SEARCH OF BIOMARKERS FOR RA? (2020) (0)
- Relation of the Serum Levels of DKK-1 and Osteoprotegerin with Bone Mass in Tightly Controlled Rheumatoid Arthritis. (2020) (0)
- FRI0649 Standardized procedures for ultrasound imaging in paediatric rheumatology: progress of a eular task force (2017) (0)
- AB0120 IDENTIFYING CORE VARIABLES TO DEVELOP A SEVERITY INDEX IN RHEUMATOID ARTHRITIS: A NATIONWIDE DELPHI CONSENSUS (2021) (0)
- FRI0457 Recommendations for The Management of Comorbidities in Psoriatic Disease (2016) (0)
- Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern (2018) (0)
- Developing guidelines for ultrarare rheumatic disorders: a bumpy ride (2022) (0)
- Country-Level Factors Associated With COVID-19-Related Death in People With Rheumatic Disease: Results From the COVID-19 Global Rheumatology Alliance Registry (2022) (0)
- Characteristics of Paget's disease in Spain. Data from the National Paget's Register (2009) (0)
- Centre-related variability in hospital admissions of patients with spondyloarthritis (2016) (0)
- FRI0106 Results of a systematic literature review of prognostic factors in rheumatoid arthritis as a basis for a prospective rheumatologists survey (2017) (0)
- THU0421 Influence of clinical, laboratory and image findings on the criteria-based diagnosis and classification of patients in new-onset spondyloarthritis units: Results from the esperanza cohort (2013) (0)
- Openreuma Consensus on the role of nursing in the care of patients with rheumatoid arthritis and diffuse interstitial lung disease (2022) (0)
- Restless farewell (2017) (0)
- FRI0306 IDIOPATHIC INFLAMMATORY MYOPATHIESAND ANTISYNTHETASE SYNDROME: CONTRIBUTION OF ANTISYNTHETASE ANTIBODIES TO IMPROVE CURRENT CLASSIFICATION CRITERIA (2019) (0)
- Reducing the Need for Central Dual-Energy X-Ray Absorptiometry in Postmenopausal Women: Efficacy of a Clinical Algorithm Including Peripheral Densitometry (2013) (0)
- AB0676 FEARS AND HOPES DURING THE COVID-19 PANDEMIC IN PATIENTS WITH RHEUMATIC DISEASES. RESULTS FROM THE REUMAVID STUDY (PHASE 1) (2021) (0)
- POS0248 PSYCHOMETRIC PROPERTIES OF OUTCOME MEASUREMENT INSTRUMENTS FOR ANCA-ASSOCIATED VASCULITIS: A SYSTEMATIC LITERATURE REVIEW (2021) (0)
- Measurement properties of outcome instruments for large-vessel vasculitis: a systematic literature review. (2022) (0)
- P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry (2022) (0)
- AB0895 Consensus Statement on the Transition Process from Pediatric Care to Adult Care in Patients with Chronic Inflammatory Rheumatic Diseases with Childhood-Onset (2014) (0)
- SP0157 PRO SESSION: IMPUTATION IS A POWERFUL ANALYTICAL TOOL, WHEN APPROPRIATELY USED (2019) (0)
- Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab. (2020) (0)
- OP0288 MACHINE LEARNING ALGORITHMS TO PREDICT COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME IN PATIENTS WITH RHEUMATIC DISEASES: RESULTS FROM THE GLOBAL RHEUMATOLOGY ALLIANCE PROVIDER REGISTRY (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Loreto Carmona?
Loreto Carmona is affiliated with the following schools:
